Baicalein external preparation and application thereof in treatment of atopic dermatitis
The invention discloses a baicalein external preparation and application thereof in treatment of atopic dermatitis, the effective component of the preparation is baicalein, and the baicalein is matched with pharmaceutic adjuvants to prepare a dosage form capable of being externally applied to skin and mucosa. The external preparation can be used for treating atopic dermatitis, has the characteristics of convenience in use and remarkable effect, and has a wide application prospect..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Europäisches Patentamt - (2024) vom: 05. Jan. Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
YE SI [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-01-05, Last update posted on www.tib.eu: 2024-03-18, Last updated: 2024-03-22 |
|---|
| Patentnummer: |
CN117338717 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA00113003X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA00113003X | ||
| 003 | DE-627 | ||
| 005 | 20240322141411.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240322s2024 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA00113003X | ||
| 035 | |a (EPA)CN117338717 | ||
| 035 | |a (EPA)89355446 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a YE SI |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Baicalein external preparation and application thereof in treatment of atopic dermatitis |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2024-01-05, Last update posted on www.tib.eu: 2024-03-18, Last updated: 2024-03-22 | ||
| 520 | |a The invention discloses a baicalein external preparation and application thereof in treatment of atopic dermatitis, the effective component of the preparation is baicalein, and the baicalein is matched with pharmaceutic adjuvants to prepare a dosage form capable of being externally applied to skin and mucosa. The external preparation can be used for treating atopic dermatitis, has the characteristics of convenience in use and remarkable effect, and has a wide application prospect. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a KOU SHUMENG |4 aut | |
| 700 | 0 | |a LI PENGHUI |4 aut | |
| 700 | 0 | |a SUN ZHONGYING |4 aut | |
| 700 | 0 | |a GUO QINGLONG |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 05. Jan. |
| 773 | 1 | 8 | |g year:2024 |g day:05 |g month:01 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/89355446/publication/CN117338717A1?q=CN117338717 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 05 |c 01 | ||